Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Postpartum disease activity and breastfeeding in multiple sclerosis revisited.
Improving the translational hit of experimental treatments in multiple sclerosis.
Use of fumaric acid esters in psoriasis.
Scientists probe strategies to repair neuron damage in multiple sclerosis.
Quantifying the early stages of remyelination following cuprizone-induced demyelination.
Parenteral Dilantin®
Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database.
New diagnostic criteria for multiple sclerosis: guidelines for research protocols.
SMC Says Yes to Aubagio® (teriflunomide), a New Once Daily First-line Oral Treatment Available for People with an Active Relapsing Remitting Form of MS
Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
BIIB033 single ascending dose study in healthy volunteer subjects
Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination.
Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity.
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.
Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis.
Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).
Remyelination in experimental models of toxin-induced demyelination.
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Teriflunomide added to interferon-β in relapsing multiple sclerosis: A randomized phase II trial.
Transfer of interferon β-1a into human breastmilk.
Relapses Requiring Intravenous Steroid Use and Multiple-Sclerosis-Related Hospitalizations: Integrated Analysis of the Delayed-Release Dimethyl Fumarate Phase III Studies.
MHC transmission: insights into gender bias in MS susceptibility.
Gene expression in brain during cuprizone-induced demyelination and remyelination.

Pages